Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, et al. Statin use and risk of pancreatic cancer: a meta-analysis. Cancer Causes Control. 2012;23:1099–111.

Article  PubMed  Google Scholar 

Ponnala V, Narapaka PK, Garapati P, Vishwas G, Imam A, Dhingra S. Exploring the association between statin use and the risk of pancreatic cancer: an updated meta-analysis of observational studies. Curr Pharmacol Rep. 2023;9:167–76.

Article  Google Scholar 

Newman TB, Hulley SB. Carcinogenicity of lipid-lowering drugs. JAMA. 1996;275:55–60.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Liang M, Sun C, Qu G, Shi T, Min M, Wu Y, Sun Y. Statin use and risk of pancreatic cancer: an updated meta-analysis of 26 studies. Pancreas. 2019;48(2):142–50.

Chen Z, Wu P, Wang J, Chen P, Fang Z, Luo F. The association of statin therapy and cancer: a meta-analysis. Lipids Health Dis. 2023;22:192.

Article  PubMed  PubMed Central  Google Scholar 

Jiang W, Hu J-W, He X-R, Jin W-L, He X-Y. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res. 2021;40:241.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Archibugi L, Piciucchi M, Stigliano S, Valente R, Zerboni G, Barucca V, et al. Exclusive and combined use of statins and aspirin and the risk of pancreatic cancer: a case-control study. Sci Rep. 2017;7:7.

Article  Google Scholar 

Bradley MC, Hughes CM, Cantwell MM, Murray LJ. Statins and pancreatic cancer risk: a nested case-control study. Cancer Causes Control. 2010;21:2093–100.

Article  PubMed  Google Scholar 

Carey FJ, Little MW, Pugh TF, Ndokera R, Ing H, Clark A, Dennison A, Metcalfe MS, Robinson RJ, Hart AR. The differential effects of statins on the risk of developing pancreatic cancer: a case–control study in two centres in the United Kingdom. Digestive diseases and sciences. 2013;58:3308–12.

Chiu H-F, Chang C-C, Ho S-C, Wu T-N, Yang C-Y. Statin use and the risk of pancreatic cancer a population-based case-control study identification of cases and control subjects. Pancreas and. 2011;40:669–72.

Article  PubMed  CAS  Google Scholar 

Choi JH, Lee SH, Huh G, Chun JW, You MS, Paik WH, et al. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: a nested case-control study in a Korean nationwide cohort. Cancer Med. 2019;8:7419–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Coogan PF, Rosenberg L, Strom BL. Statin use and the risk of 10 cancers. Epidemiology. 2007;18:213–9.

Article  PubMed  Google Scholar 

Dorais M, Tamaz R, Rakel A, LeLorier J, Panzini B. Statins, NSAIDs, and pancreatic cancer. InPharmacoepidemiology and drug safety. 2007;16:S93–S93.

Fujimoto M, Higuchi T, Hosomi K, Takada M. Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database. Int J Med Sci. 2015;12:223–33.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Graaf MR, Beiderbeck AB, Egberts ACG, Richel DJ, Guchelaar HJ. The risk of cancer in users of statins. J Clin Oncol. 2004;22:2388–94.

Article  PubMed  CAS  Google Scholar 

Kaye JA, Jick H. Statin use and cancer risk in the General Practice Research Database. Br J Cancer. 2004;90:635–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kho PF, Fawcett J, Fritschi L, Risch H, Webb PM, Whiteman DC, Neale RE. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case–control study. Cancer Causes Control. 2016;27:1457–64.

Khurana V, Sheth A, Caldito G, Barkin JS. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans. Pancreas. 2007;34:260–5.

Article  PubMed  CAS  Google Scholar 

Leung HWC, Chan ALF, Lo D, Leung JH, Chen H-L. Common cancer risk and statins: a population-based case-control study in a Chinese population. Expert Opin Drug Saf. 2013;12:19–27.

Article  PubMed  CAS  Google Scholar 

Pugh TFG, Little M, Carey F, Metcalfe M, Robinson R, Clark A, et al. Aspirin, NSAIDS, calcium-channel blockers and statins in the aetiology of pancreatic cancer: preliminary results from a case-control study in two centres in the UK. Gut. 2011;60:A81–A81.

Article  Google Scholar 

Walker EJ, Ko AH, Holly EA, Bracci PM. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study. Cancer. 2015;121:1287–94.

Article  PubMed  CAS  Google Scholar 

Bang UC, Watanabe T, Bendtsen F. The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis. Eur J Gastroenterol Hepatol. 2018;30(3):346–51.

Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CPJ, Habel LA. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008;17:27–36.

Article  PubMed  Google Scholar 

Gazzerro P, Proto MC, Gangemi G, Malfitano AM, Ciaglia E, Pisanti S, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev. 2012;64:102–46.

Article  PubMed  CAS  Google Scholar 

Hamada T, Khalaf N, Yuan C, Babic A, Morales-Oyarvide V, Qian ZR, Nowak JA, Ng K, Kraft P, Rubinson DA, Stampfer MJ. Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018;53:959–66.

Hamada T, Khalaf N, Yuan C, Morales-Oyarvide V, Babic A, Nowak JA, et al. Prediagnosis use of statins associates with increased survival times of patients with pancreatic cancer. Clin Gastroenterol Hepatol. 2018;16:1300-1306.e3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, et al. Incidence of cancer and statin usage–record linkage study. Int J Cancer. 2010;126:279–84.

Article  PubMed  CAS  Google Scholar 

Huang BZ, Chang JI, Li E, Xiang AH, Wu BU. Influence of statins and cholesterol on mortality among patients with pancreatic cancer. J Natl Cancer Inst. 2017;109(5):djw275.

Jacobs EJ, Newton CC, Thun MJ, Gapstur SM. Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort. Can Res. 2011;71:1763–71.

Article  CAS  Google Scholar 

Kirkegård J, Lund JL, Mortensen FV, Cronin-Fenton D. Statins and pancreatic cancer risk in patients with chronic pancreatitis: a Danish nationwide population-based cohort study. Wiley Online Libr. 2019;146:610–6.

Google Scholar 

Lee HS, Lee SH, Lee HJ, Chung MJ, Park JY, Park SW, et al. Statin use and its impact on survival in pancreatic cancer patients. Medicine (United States). 2016;95(19):e3607.

Claudio M, Candace G, Susan R, Sara H, SD F, Paul C et al. Statins and risk of cancer. J Am College Cardiol. 2011;58:530–7.

Moon DC, Lee HS, Il Lee Y, Chung MJ, Park JY, Park SW, et al. Concomitant statin use has a favorable effect on gemcitabine-erlotinib combination chemotherapy for advanced pancreatic cancer. Yonsei Med J. 2016;57:1124–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nakai Y, Isayama H, Sasaki T, Mizuno S, Sasahira N, Kogure H, et al. Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: Better prognosis with statin use in diabetic patients. Pancreas. 2013;42:202–8.

Article  PubMed  CAS  Google Scholar 

Saito K, Sato Y, Nakatani E, Kaneda H, Yamamoto S, Miyachi Y, Itoh H. Statin exposure and pancreatic cancer incidence: a Japanese regional population-based cohort study, the Shizuoka study. Cancer Prev Res. 2021;14(9):863–72.

Simon MS, Desai P, Wallace R, Wu C, Howard BV, Martin LW, et al. Prospective analysis of association between statins and pancreatic cancer risk in the Women’s Health Initiative. Cancer Causes Control. 2016;27:415–23.

Article  PubMed  PubMed Central  Google Scholar 

Støer NC, Bouche G, Pantziarka P, Sloan EK, Andreassen BK, Botteri E. Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway. Acta Oncol. 2021;60:1146–53.

Article  PubMed  Google Scholar 

Iarrobino NA, Gill B, Bernard ME, Mishra MV, Champ CE. Targeting tumor metabolism with statins during treatment for advanced-stage pancreatic cancer. 2018;41(11):1125–31.

Wu BU, Chang J, Jeon CY, Pandol SJ, Huang B, Ngor EW, et al. Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. Am J Gastroenterol. 2015;110:1233–9.

Article  PubMed  PubMed Central  CAS  Google Scholar